Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 4:05 AM
Ignite Modification Date:
2025-12-25 @ 4:05 AM
NCT ID:
NCT02868502
Eligibility Criteria:
Inclusion Criteria:
* OAG patients
* Ocular Hypertension (OHT) patients
* Healthy subjects, without any ocular pathology (except for refraction errors, past cataract surgery, strabismus or amblyopia).
Exclusion Criteria:
* Other intraocular surgeries within the past 3 months
* Illness effecting episcleral venous pressure, such as superior vena cava syndrome, thyroid eye disease, orbital masses
* Patients who are unable to maintain supine position for 15 minutes
* Corneal abnormalities: epithelial pathologies, corneal infection, corneal erosions, corneal scars, keratoconus, S/P corneal transplantation (lamellar/full thickness)
* Hypersensitivity to oxybuprocaine hydrochloride
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
95 Years
Study:
NCT02868502
Study Brief:
Protocol Section:
NCT02868502